Aspen Pharmacare agrees Merck plant acquisition

Financial Times 27 June 2013
Aspen Pharmacare has agreed to buy a manufacturing plant from Merck of the US as part of a $1bn deal, as the South African group builds up its global presence.
Aspen said the transaction would involve it taking over a plant in the Netherlands, as well as a satellite facility and sales office in the US.
It would also have an option to acquire 11 branded drugs that cover a range of therapeutic areas.
Last week, Aspen said it was in talks with GlaxoSmithKline to acquire its Fraxiparine/Fraxodi brands of thrombosis drugs, except in China, Pakistan and India.
Read more…